Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ching-Wei Chang

Showing results (81-90 of 102) with videos related to

Pageof 11
Sort By:
International Journal of Molecular Sciences|January 16, 2020
Fecal Microbiota Transplantation Prevents Intestinal Injury, Upregulation of Toll-Like Receptors, and 5-Fluorouracil/Oxaliplatin-Induced Toxicity in Colorectal CancerChing-Wei Chang, Hung-Chang Lee, Li-Hui Li, et al.
Birth Defects Research. Part B, Developmental and Reproductive Toxicology|February 25, 2015
Effects of maternal and lactational exposure to 2-hydroxy-4-methoxybenzone on development and reproductive organs in male and female rat offspringNoriko Nakamura, Amy L Inselman, Gene A White, et al.
Journal of Gastroenterology and Hepatology|January 11, 2013
Gender-specific association of the interleukin 18 gene with symptomatic gallstone diseaseShou-Chuan Shih, Horng-Woei Yang, Tzu-Yang Chang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 2023
An Open-label Phase I Study of GDC-0927 in Postmenopausal Women with Locally Advanced or Metastatic Estrogen Receptor-Positive Breast CancerSarat Chandarlapaty, Maura N Dickler, Jose Alejandro Perez Fidalgo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2022
VERONICA: Randomized Phase II Study of Fulvestrant and Venetoclax in ER-Positive Metastatic Breast Cancer Post-CDK4/6 Inhibitors - Efficacy, Safety, and Biomarker ResultsGeoffrey J Lindeman, Tharu M Fernando, Rebecca Bowen, et al.
Nature Communications|November 5, 2020
Integrated digital pathology and transcriptome analysis identifies molecular mediators of T-cell exclusion in ovarian cancerMélanie Desbois, Akshata R Udyavar, Lisa Ryner, et al.
Journal of Proteome Research|August 22, 2017
Membrane Proteomics of Impaired Energetics and Cytoskeletal Disorganization in Elderly Diet-Induced Diabetic MiceChung-Lieh Hung, Szu-Hua Pan, Chia-Li Han, et al.
The Journal of Pathology|March 25, 2024
Automated tumor immunophenotyping predicts clinical benefit from anti-PD-L1 immunotherapyXiao Li, Jeffrey Eastham, Jennifer M Giltnane, et al.
Science Translational Medicine|September 21, 2022
Giredestrant reverses progesterone hypersensitivity driven by estrogen receptor mutations in breast cancerJackson Liang, Ellen Rei Ingalla, Xiaosai Yao, et al.
Toxicology and Applied Pharmacology|April 18, 2012
In vivo genotoxicity of furan in F344 rats at cancer bioassay dosesWei Ding, Dayton M Petibone, John R Latendresse, et al.
Pageof 11

Showing results (81-90 of 102) with videos related to

Sort By:
Pageof 11
International Journal of Molecular Sciences|January 16, 2020
Fecal Microbiota Transplantation Prevents Intestinal Injury, Upregulation of Toll-Like Receptors, and 5-Fluorouracil/Oxaliplatin-Induced Toxicity in Colorectal CancerChing-Wei Chang, Hung-Chang Lee, Li-Hui Li, et al.
Birth Defects Research. Part B, Developmental and Reproductive Toxicology|February 25, 2015
Effects of maternal and lactational exposure to 2-hydroxy-4-methoxybenzone on development and reproductive organs in male and female rat offspringNoriko Nakamura, Amy L Inselman, Gene A White, et al.
Journal of Gastroenterology and Hepatology|January 11, 2013
Gender-specific association of the interleukin 18 gene with symptomatic gallstone diseaseShou-Chuan Shih, Horng-Woei Yang, Tzu-Yang Chang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 2023
An Open-label Phase I Study of GDC-0927 in Postmenopausal Women with Locally Advanced or Metastatic Estrogen Receptor-Positive Breast CancerSarat Chandarlapaty, Maura N Dickler, Jose Alejandro Perez Fidalgo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2022
VERONICA: Randomized Phase II Study of Fulvestrant and Venetoclax in ER-Positive Metastatic Breast Cancer Post-CDK4/6 Inhibitors - Efficacy, Safety, and Biomarker ResultsGeoffrey J Lindeman, Tharu M Fernando, Rebecca Bowen, et al.
Nature Communications|November 5, 2020
Integrated digital pathology and transcriptome analysis identifies molecular mediators of T-cell exclusion in ovarian cancerMélanie Desbois, Akshata R Udyavar, Lisa Ryner, et al.
Journal of Proteome Research|August 22, 2017
Membrane Proteomics of Impaired Energetics and Cytoskeletal Disorganization in Elderly Diet-Induced Diabetic MiceChung-Lieh Hung, Szu-Hua Pan, Chia-Li Han, et al.
The Journal of Pathology|March 25, 2024
Automated tumor immunophenotyping predicts clinical benefit from anti-PD-L1 immunotherapyXiao Li, Jeffrey Eastham, Jennifer M Giltnane, et al.
Science Translational Medicine|September 21, 2022
Giredestrant reverses progesterone hypersensitivity driven by estrogen receptor mutations in breast cancerJackson Liang, Ellen Rei Ingalla, Xiaosai Yao, et al.
Toxicology and Applied Pharmacology|April 18, 2012
In vivo genotoxicity of furan in F344 rats at cancer bioassay dosesWei Ding, Dayton M Petibone, John R Latendresse, et al.
Pageof 11